Celgene Corp (NASDAQ: CELG)DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 05/17/2019
Closing price: 95.42
|Support price level:||$92.84|
|Resistance price level:||N/A|
|Relative strength index (14-day RSI)||55.7|
- CELG is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- The price of this high-beta stock is expected to increase by 1.48% for every 1% increase in the S&P-500.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
|Low||High||Price as % of Range|
|200 day||50 day||20 day||10 day|
|Last month||Current estimate||Next month forecast|
- 6.7% in the next week.
- 15.8% in the next month.
- 68.5% in the next year.